Baxter’s Recall Of Spectrum Infusion Pumps Given Class I Label By FDA

The US agency said the device maker initiated the recall in December because the pumps might not alarm for repeated occlusion events.

Baxter building in Mississauga, Ontario.
• Source: Shutterstock

More from Recalls

More from Policy & Regulation